LIXTE Biotechnology Transforms to AI Energy Infrastructure; Adds Stuart Porter to Board

Key Highlights

• LIXTE Biotechnology is strategically transforming into an AI energy infrastructure equipment & services platform.
• The transformation aims to meet the rapidly growing power demands of AI and hyperscale data centers.
• Stuart D. Porter, Founder and CEO of Denham Capital, was appointed to the Board of Directors.
• Mr. Porter brings over 29 years of senior investment experience in energy and commodities sectors.
• LIXTE will focus on power equipment and service solutions for hyperscale AI and data-center campuses.
• The company will also target equipment for distributed and behind-the-meter power systems.
• LIXTE plans to seek a strategic acquisition partner for its clinical stage pharmaceutical and med-tech operations.
• Denham Capital's infrastructure group is advancing a 10 GW pipeline of AI data-center-oriented power generation assets.